INPPL1 and cancer: Aberrant expression of SHIP2 in human cancers has been found in various tumors including breast, hepatocellular, non-small cell lung, colorectal, gastric cancer cells, and aberrant SHIP2 expression is correlated with malignant potential and poor survival of patients [4,9,10,11,12].